참고문헌
- Embryotoxikologische probleme in der Arzneimittelforschung AMI-Berichte BGA;B.Schneider(et al.)(eds.)
- Stain. Technol. v.1 A note on the staining of the skeleton of cleared specimens with Alizarin Red S Dawson,A.B.
- Proceedings of the International Symposium held at the Seoul Palace Hotel, Seoul, Korea Experience in the safety testing for biotechnology products and problems generated by animal studies Harada,Y.;Y.N.Cha(et al.)(eds.)
- Cong. Anom. v.16 Differentitial staining of cartilage and bone in fetal mouse skeleton by alcian blue and alizarin red S Inouye,M.
- Reproduction Studies: A Review of Test Protocols for Pharmaceuticals, Agrochemicals, Food Additivies and Industrial Chemicals According to European, American and Japanese Guidelines Inveresk Reseach International
- Proceedings of the International Symposium held at the Seoul Palace hotel, Seoul, Korea The toxicology of industrial biotechnology products Lewandowski,M.;Y.N.Cha(et al.)(eds.)
- Methods in Prenatal Toxicology Evaluation of Skeleton Lorke,D.;D.Neubert(et al.)(eds.)
- Principles and Methods of Toxicology Test methods for assessing female reproductive and developmental toxicology Manson,J.M.;Kang,Y.J.;W.Hayes(et al.)(eds.)
- Cong. Anom. v.27 Spontaneous malformations in laboratory animals: Frequency of external, internal and skeletal malformations in rats, rabbits and mice Morita,H.;Ariyuki,F.;Inomata,N.;Nishimura,K.;Kasegawa,Y.;Miyamoto,M.;Watanable,T.
- Toxicity Test Guideline for Safety Evaluation of Drugs for Human Use (X) National Institute for Safety Research
- Cong. Anom. v.14 no.1 A microdissection method for detecting thoracic visceral malformations in mouse and rat fetuses Nishimura,K.
- Methods in Prenatal Toxocology Incidence of sporadic malformations, anomalies and variations in random bred laboratory animals Palmer,A.K.;D.Neubert(et al.)(eds.)
- Cancer v.57 The preclinical development of Roferon-A Trown,P.W.;Wills,R.J.;Kamm,J.J.
- Principles and Techniques Teratology Wilson,J.G.;Warkany,J.
- Toxicity Test Guideline: Collection of notifications related to the pharmaceutical affairs law (IV) Yakugyo Jiho Co